Picture of Vyant Bio logo

VYNT — Vyant Bio News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Cancer Genetics Q3 Earnings Per Share $0.98

Nov 20 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS REPORTS THIRD QUARTER 2019 FINANCIAL
RESULTS AND
PROVIDES STRATEGIC BUSINESS UPDATE
    * Q3 EARNINGS PER SHARE $0.98
    * CANCER GENETICS - TOTAL DISCOVERY SERVICES REVENUE OF $2.1
MILLION FOR Q3 OF 2019 COMPARED TO REVENUE OF $0.5 MILLION IN Q3
OF 2018
    * CANCER GENETICS - RETAINED HC WAINWRIGHT & CO. TO EXPLORE
STRATEGIC ALTERNATIVES FOR FUTURE MERGER, SALE OF ASSETS, OR
OTHER STRATEGIC TRANSACTIONS

Source text for Eikon:  ID:nGNX23h4HP 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vyant Bio

See all news